Compounding Pharmacies Market Size, Share, Sales, Analysis, Forecast By Dosage Forms (Solid Oral Preparations, Liquid Preparations, Topical, Ophthalmic, Nasal and Others), By Therapeutic Area (hormone replacement, pain management, dermatology applications, specialty drugs, nutritional supplements and Others), By Compounding Type (Pharmaceutical Ingredient Alteration (PIA), Pharmaceutical Application Alteration (PAA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA) and Specialised Animal Pharmaceutical Manufacturing (SAPM)), By Sterility (Sterile Dosage Form and Non-Sterile Dosage Form), By End User (Adult, Geriatric, Pediatric And Veterinary), Industry Competition & Player Profiles, 2023 – 2032
The Global Compounding Pharmacies Market size was estimated to be US$ 9 billion in 2019 and is expected to grow at a CAGR of 5% through 2030.
The compounding pharmacy is an alternative to the mass produced drugs. The patients choose compounding pharmacy when they have been prescribed to a drug containing a substance that they are allergic to.
Another occasion of choosing compounding pharmacy includes prescription of a drug that has been discontinued by mass drug producer. The spread of sedentary lifestyle has increased the cases of hormonal imbalance. The compounded hormones have been proved to be effective in treatment of hormonal imbalance. In the United States there are two broad categories of compounding pharmacy, 503A pharmacies can formulate drugs for an individual patient prescription and are regulated by respective states.
The other category, 503B outsourcing facilities are capacitated to supply drugs directly to hospitals and clinics and are regulated by both state and the FDA. The compounded drugs produced by clinics and hospitals in large quantities are termed as ‘office stock’. Oral compounded drugs have registered highest demand owing to the ease of ingestion and long shelf life.
North America contributed a dominating share to the global compounding pharmacies market in 2019, followed by Europe. The presence of multiple prominent players across North America has led to heavy revenue generation in the region. Compounding labs have been producing and supplying compounding nutritional supplements. These supplements are prescribed by the nutritionists to prevent and cure chronic dietary disorders.
Shortage of drugs across North America is a strong reason for growth of compounding pharmacies across the region. Asia Pacific is anticipated to witness gripping demand through the forecast period. Japan, China and India would lead this growth owing to awareness across patients.
Compounding Pharmacies Market Share Analysis, by Geography (2022)
The report titled “Compounding Pharmacies Market - Global Market Share, Trends, Analysis and Forecasts, 2023-2032” wherein 2022 is historic period, 2022 is the base year, and 2023 to 2032 is forecast period. Additionally, the study takes into consideration the competitive landscape, wherein the report would provide company overview and market outlook for leading players in the global compounding pharmacies market.
Furthermore, the report would reflect the key developments, global & regional sales network, business strategies, research & development activities, employee strength, and key executive, for all the major players operating in the market.
The global compounding pharmacies market is segmented on the basis of dosage forms, therapeutic area, compounding type, sterility, end users and geography. Based on dosage forms, the global compounding pharmacies market is segmented into solid oral preparations, liquid preparations, topical, ophthalmic, nasal, and others. Based on therapeutic area global compounding pharmacies market is segmented into hormone replacement, pain management, dermatology applications, specialty drugs, nutritional supplements and others. Based on compounding type global compounding pharmacies market is segmented into Pharmaceutical Ingredient Alteration (PIA), Pharmaceutical Application Alteration (PAA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA) and Specialised Animal Pharmaceutical Manufacturing (SAPM). Based on sterility global compounding pharmacies market is segmented into sterile dosage form and non-sterile dosage form. Based on end user global compounding pharmacies market is segmented into adult, geriatric, pediatric and veterinary. Based on geography, the global compounding pharmacies market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South America.
The research provides in-depth analysis of prominent players holding majority share of the global market with a focus on all operating business segment, and would identify the segment of the company focusing on compounding pharmacy products. Further, market share of prominent companies in the global compounding pharmacies market would also be estimated. The study takes into consideration the key competitive information such as business strategy, product portfolio, key development, SWOT analysis, and research and development focus of all the compounding pharmacy companies.
The global compounding pharmacies market study would take into consideration the participants engaged throughout the supply chain and value chain of the market, along with their contribution. Product portfolio would focus on all the products under the relevant business segment of the company.
Similarly, the recent development section would focus on the latest developments of company such as strategic alliances and partnerships, merger and acquisition, new product launched and geographic expansion in the global compounding pharmacies market.
Major players active in the global compounding pharmacies market include B. Braun Medical, Fagron, Dougherty's Pharmacy, Fresenius Kabi, Clinigen Group PLC, Institutional Pharmacy Solutions, Lorraine’s Pharmacy, Cantrell Drug Company, PharMEDium, Premier Pharmacy Labs, McKesson Corporation, McGuff Compounding Pharmacy Services, Nephron Pharmaceuticals, Pencol Compounding Pharmacy, Pentec Health, Rx3 Compounding Pharmacy, RXQ Compounding Pharmacy, Triangle Compounding Pharmacies, Wedgewood Village Pharmacy, Wells Pharmacy Network and others.
Market Segmentation:
By Dosage Forms
- Solid Oral Preparations
- Liquid Preparations
- Topical
- Ophthalmic
- Nasal
- Others
By Therapeutic Area
- Hormone Replacement
- Pain Management
- Dermatology Applications
- Specialty Drugs
- Nutritional Supplements
- Others.
By Compounding Type
- Pharmaceutical Ingredient Alteration (PIA)
- Pharmaceutical Application Alteration (PAA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Pharmaceutical Dosage Alteration (PDA)
- Specialised Animal Pharmaceutical Manufacturing (SAPM)
By Sterility
- Sterile Dosage Form
- Non-Sterile Dosage Form
By End Users
- Adult
- Geriatric
- Pediatric
- Veterinary
By Geography
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
- Introduction
- Research Objectives
- Report Assumptions
- Research Methodology
- Abbreviations
- Preface
- Market Definition
- Report Scope and Market Segmentation
- Research Highlights
- Market Synopsis: Global Compounding Pharmacies Market
- Global Compounding Pharmacies Market Qualitative Analysis
- Ecosystem Analysis
- Role of participants
- Integration scenario
- Trends
- Market trends
- Technology Trends
- PESTLE Analysis (For 5 prominent countries)
- Market Influencers
- Driving Forces
- Hindering Forces
- Opportunities
- Insurance and Reimbursement
- COVID-19 situation
- Budget allocation – Recent past and future
- Forward path
- Ecosystem Analysis
- Global Compounding Pharmacies Market Analysis and Forecast, by Dosage Forms
- Overview and definitions
- Key segment analysis
- Global Compounding Pharmacies Market Estimates (US$ Mn), by Dosage Forms, 2019 – 2032
- Solid Oral Preparation
- Liquid Preparation
- Topical
- Ophthalmic
- Nasal
- Others
- Global Compounding Pharmacies Market Analysis and Forecast, by Therapeutic Area
- Overview and definitions
- Key segment analysis
- Global Compounding Pharmacies Market Estimates (US$ Mn), by Therapeutic Area, 2019 – 2032
- Hormone Replacement
- Pain Management
- Dermatology applications
- Specialty Drugs
- Nutritional Supplements
- Others
- Global Compounding Pharmacies Market Analysis and Forecast, by Compounding Type
- Overview and definitions
- Key segment analysis
- Global Compounding Pharmacies Market Estimates (US$ Mn), by Compounding Type, 2019 – 2032
- Pharmaceutical Ingredient Alteration (PIA)
- Pharmaceutical Application Alteration (PAA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Pharmaceutical Dosage Alteration (PDA)
- Specialised Animal Pharmaceutical Manufacturing (SAPM)
- Global Compounding Pharmacies Market Analysis and Forecast, by Sterility
- Overview and definitions
- Key segment analysis
- Global Compounding Pharmacies Market Estimates (US$ Mn), Sterility, 2019 – 2032
- Sterile Dosage Form
- Non-Sterile Dosage Form
- Global Compounding Pharmacies Market Analysis and Forecast, by Region
- Overview and definitions
- Key segment analysis
- Global Compounding Pharmacies Market Estimates (US$ Mn), by Region, 2019 – 2032
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
- North America Compounding Pharmacies Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- North America Compounding Pharmacies Market Estimates (US$ Mn), by Dosage Forms, 2019 – 2032
- Solid Oral Preparation
- Liquid Preparation
- Topical
- Ophthalmic
- Nasal
- Others
- North America Compounding Pharmacies Market Estimates (US$ Mn), by Therapeutic Area, 2019 – 2032
- Hormone Replacement
- Pain Management
- Dermatology applications
- Specialty Drugs
- Nutritional Supplements
- Others
- North America Compounding Pharmacies Market Estimates (US$ Mn), by Compounding Type, 2019 – 2032
- Pharmaceutical Ingredient Alteration (PIA)
- Pharmaceutical Application Alteration (PAA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Pharmaceutical Dosage Alteration (PDA)
- Specialised Animal Pharmaceutical Manufacturing (SAPM)
- North America Compounding Pharmacies Market Estimates (US$ Mn), Sterility, 2019 – 2032
- Sterile Dosage Form
- Non-Sterile Dosage Form
- North America Compounding Pharmacies Market Estimates (US$ Mn), Country, 2019 – 2032
- The U.S.
- Canada
- Rest of North America
- Europe Compounding Pharmacies Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Europe Compounding Pharmacies Market Estimates (US$ Mn), by Dosage Forms, 2019 – 2032
- Solid Oral Preparation
- Liquid Preparation
- Topical
- Ophthalmic
- Nasal
- Others
- Europe Compounding Pharmacies Market Estimates (US$ Mn), by Therapeutic Area, 2019 – 2032
- Hormone Replacement
- Pain Management
- Dermatology applications
- Specialty Drugs
- Nutritional Supplements
- Others
- Europe Compounding Pharmacies Market Estimates (US$ Mn), by Compounding Type, 2019 – 2032
- Pharmaceutical Ingredient Alteration (PIA)
- Pharmaceutical Application Alteration (PAA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Pharmaceutical Dosage Alteration (PDA)
- Specialised Animal Pharmaceutical Manufacturing (SAPM)
- Europe Compounding Pharmacies Market Estimates (US$ Mn), Sterility, 2019 – 2032
- Sterile Dosage Form
- Non-Sterile Dosage Form
- Europe Compounding Pharmacies Market Estimates (US$ Mn), Country, 2019 – 2032
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific Compounding Pharmacies Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Asia Pacific Compounding Pharmacies Market Estimates (US$ Mn), by Dosage Forms, 2019 – 2032
- Solid Oral Preparation
- Liquid Preparation
- Topical
- Ophthalmic
- Nasal
- Others
- Asia Pacific Compounding Pharmacies Market Estimates (US$ Mn), by Therapeutic Area, 2019 – 2032
- Hormone Replacement
- Pain Management
- Dermatology applications
- Specialty Drugs
- Nutritional Supplements
- Others
- Asia Pacific Compounding Pharmacies Market Estimates (US$ Mn), by Compounding Type, 2019 – 2032
- Pharmaceutical Ingredient Alteration (PIA)
- Pharmaceutical Application Alteration (PAA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Pharmaceutical Dosage Alteration (PDA)
- Specialised Animal Pharmaceutical Manufacturing (SAPM)
- Asia Pacific Compounding Pharmacies Market Estimates (US$ Mn), Sterility, 2019 – 2032
- Sterile Dosage Form
- Non-Sterile Dosage Form
- Asia Pacific Compounding Pharmacies Market Estimates (US$ Mn), Country, 2019 – 2032
- Japan
- India
- China
- Australia
- Rest of Asia Pacific
- Middle East & Africa Compounding Pharmacies Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- Middle East & Africa Compounding Pharmacies Market Estimates (US$ Mn), by Dosage Forms, 2019 – 2032
- Solid Oral Preparation
- Liquid Preparation
- Topical
- Ophthalmic
- Nasal
- Others
- Middle East & Africa Compounding Pharmacies Market Estimates (US$ Mn), by Therapeutic Area, 2019 – 2032
- Hormone Replacement
- Pain Management
- Dermatology applications
- Specialty Drugs
- Nutritional Supplements
- Others
- Middle East & Africa Compounding Pharmacies Market Estimates (US$ Mn), by Compounding Type, 2019 – 2032
- Pharmaceutical Ingredient Alteration (PIA)
- Pharmaceutical Application Alteration (PAA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Pharmaceutical Dosage Alteration (PDA)
- Specialised Animal Pharmaceutical Manufacturing (SAPM)
- Middle East & Africa Compounding Pharmacies Market Estimates (US$ Mn), Sterility, 2019 – 2032
- Sterile Dosage Form
- Non-Sterile Dosage Form
- Middle East & Africa Compounding Pharmacies Market Estimates (US$ Mn), Country, 2019 – 2032
- Saudi Arabia
- UAE
- Rest of Middle East
- South America Compounding Pharmacies Market Analysis and Forecast
- Overview and definitions
- Key segment analysis
- South America Compounding Pharmacies Market Estimates (US$ Mn), by Dosage Forms, 2019 – 2032
- Solid Oral Preparation
- Liquid Preparation
- Topical
- Ophthalmic
- Nasal
- Others
- South America Compounding Pharmacies Market Estimates (US$ Mn), by Therapeutic Area, 2019 – 2032
- Hormone Replacement
- Pain Management
- Dermatology applications
- Specialty Drugs
- Nutritional Supplements
- Others
- South America Compounding Pharmacies Market Estimates (US$ Mn), by Compounding Type, 2019 – 2032
- Pharmaceutical Ingredient Alteration (PIA)
- Pharmaceutical Application Alteration (PAA)
- Currently Unavailable Pharmaceutical Manufacturing (CUPM)
- Pharmaceutical Dosage Alteration (PDA)
- Specialised Animal Pharmaceutical Manufacturing (SAPM)
- South America Compounding Pharmacies Market Estimates (US$ Mn), Sterility, 2019 – 2032
- Sterile Dosage Form
- Non-Sterile Dosage Form
- South America Compounding Pharmacies Market Estimates (US$ Mn), Country, 2019 – 2032
- Brazil
- Rest of South America
- Competition Analysis – Compounding Pharmacies Market
- Market Composition
- Market Share Analysis (%), by Supplier (2022)
- Company Profiles
- Braun Medical
- Business overview
- Geographic presence
- Product portfolio
- Financial facts
- Channel partners
- Relevant news and strategic view
- Fagron NV
- Dougherty's Pharmacy
- Fresenius Kabi
- Clinigen Group PLC
- Institutional Pharmacy Solutions
- Lorraine’s Pharmacy
- PharMEDium
- McKesson Corporation
- McGuff Compounding Pharmacy Services
- Nephron Pharmaceuticals
- Pencol Compounding Pharmacy
- Pentec Health
- Rx3 Compounding Pharmacy
- RXQ Compounding Pharmacy
- Triangle Compounding Pharmacies
- Wedgewood Village Pharmacy
- Braun Medical
- Conclusion & Recommendations
Frequently asked questions about this report
Which segment accounted for the largest compounding pharmacies market share?
North America contributed a dominating share to the global compounding pharmacies market followed by Europe. The presence of multiple prominent players across North America has led to heavy revenue generation in the region. Compounding labs have been producing and supplying compounding nutritional supplements.
What are the different therapeutic area of compounding pharmacies used?
Based on therapeutic area, the compounding pharmacies market is segmented into hormone replacement, pain management, dermatology applications, specialty drugs, nutritional supplements and others.
What segments are covered in the compounding pharmacies market report?
The global compounding pharmacies market segmented on the basis of dosage forms, therapeutic area, compounding type, sterility, end users and geography.
What is the base year considered in the compounding pharmacies market report?
The base year considered in compounding pharmacies market report is 2022.